Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-02-04

Clinical Trial Update: The Effect of Omalizumab on Allergic Rhinitis Symptoms: a Comparative Study [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the effect of omalizumab on allergic rhinitis symptoms, with a comparative design and completed status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Omalizumab (Omalizumab)

Snippet

Sponsor: Yuzuncu Yil University | Conditions: Allergic Rhinitis | Phase 4 | Status: COMPLETED